Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - The EARS II study

European Journal of Clinical Investigation

Volumn 30, Issue 7, 2000, Pages 578-585

  Tiret, L ^a   Gerdes, C ^d   Murphy, M J ^b,e   Dallongeville, J ^a   Nicaud, V ^a   O'Reilly, D S J ^b,e   Beisiegel, U ^c   De Backer, G ^f  

^a INSERM   (France)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^f Royal Infirmary Hospital ^*

Author keywords

Case control study; Lp C III:B; Offspring; Postprandial lipemia; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; FAT; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CONTROLLED STUDY; DIET RESTRICTION; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; FAT INTAKE; FATHER; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL INTOLERANCE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; DIETARY FATS; FAMILY HEALTH; FATHERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; TRIGLYCERIDES;

EID: 0033922196     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00674.x     Document Type: Article

References (26)

1. 1 Cambien F, Poirier O, Mallet C, Tiret L. Coronary heart disease and genetics: an epidemiologist's view. Mol Med Today 1997;3:197-202.
2. 2 WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project - Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;91:583-612.
3. 3 EARS Group. The European Atherosclerosis Research Study: design and objectives. Int J Epidemiol 1994;23:465-71.
4. 4 EARS Group. The distribution of fasting plasma lipid concentrations in the offspring of men with premature coronary heart disease in Europe. Int J Epidemiol 1994;23:472-81.
5. 5 Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, et al. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. Circulation 1994;89:1967-73.
6. 6 Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;3:473-85.
7. 7 Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999;246:341-55.
8. 8 Siedel J, Schiefer S, Rosseneu M, Bergeaud R, De Keersgieter W, Pautz B, et al. Immunoturbidimetric method for routine determinations of apolipoprotein A-I, apolipoprotein A-II and apolipoprotein B in normolipemic and hyperlipemic sera compared with immunonephelometry. Clin Chem 1988;34:1821-5.
9. 9 Bury J, Vercaemst R, Rosseneu M, Belpaire F. Quantitation of human apolipoprotein E by enzyme-linked immunosorbent assay. Clin Chem 1986;32:265-70.
10. 10 Kandoussi A, Cachera C, Parsy D, Bard J, Fruchart J. Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo CIII and apo B with apo E. J Immunoassay 1991;12:305-23.
11. 11 Kee F, Nicaud V, Tiret L, Evans A, O'Reilly D, De Backer G. Short stature and heart disease: nature or nurture? Int J Epidemiol 1997;26:748-56.
12. 12 Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980;61:503-8.
13. 13 Barret-Connor E, Khaw KT. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984;6:1065-9.
14. 14 Myers RH, Kiely DK, Cupples LA, Kannel WB. Parental history is an independent risk factor for coronary heart disease: the Framingham Study. Am Heart J 1990;120:963-9.
15. 15 Uiterwaal CS, Grobbee DE, Witteman JCM, van Stiphout W, Krauss XH, Havekes LM, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994;121:576-83.
16. 16 Slyper A, Zvereva S, Schectman G, Hoffmann R, Pleuss J, Walker J. Normal postprandial lipemia and chylomicron clearance in offspring of parents with early coronary artery disease. J Clin Endocrinol Metab 1998;83:1106-13.
17. 17 Bjorkegren J, Packard C, Hamsten A, Bedford D, Caslake M, Foster L, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996;37:76-86.
18. 18 Dallongeville J, Baugé E, Lebel P, Fruchart JC. Fat ingestion is associated with increased levels of apoCIII- and apoE-B-containing lipoprotein particles in human. Eur J Clin Invest 1997;27:1055-60.
19. 19 Blankenhorn D, Alaupovic P, Wickham E, Chin H, Azen S. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts lipid and nonlipid factors. Circulation 1990;81:470-6.
20. 20 Parra H, Arveiler D, Evans A, Cambou J, Amouyel P, Bingham A, et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992;12:701-7.
21. 21 Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations - Studies in the fasting and postprandial states: The European Atherosclerosis Research Studies. Circulation 1997;96:733-40.
22. 22 Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ, on behalf of the EARS Group. Lipoprotein lipase gene variation is associated with paternal history of premature coronary artery disease and fasting and post-prandial plasma triglycerides: European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 1998;18:526-34.
23. 23 Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud P, et al. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII. B. The European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 1999;19:303-8.
24. 24 Waterworth D, Ribalta J, Nicaud V, Dallongeville J, Humphries S, Talmud P. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 1999;99:1872-7.
25. 25 Fisher R, Burke H, Nicaud V, Ehnholm C, Humphries S, on behalf of the EARS Group. Effect of variation in the apo AIV gene on body mass index and fasting and posprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res 1999;40:287-94.
26. 26 Dallongeville J, Tiret L, Visvikis S, Talmud P, O'Reilly D, De Backer G, et al. Effect of ApoE phenotype on postprandial triglycerides levels in young male with and without a familial history of myocardial infarction: the EARSII Study. Atherosclerosis 1999;145:381-8.